AI assistant
Sending…
MASTEC INC — Director's Dealing 2003
Aug 18, 2003
30366_dirs_2003-08-18_e829377b-63b5-406c-a13e-e0062d445107.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MASTEC INC (mtz)
CIK: 0000015615
Period of Report: 2003-08-14
Reporting Person: MAS JOSE RAMON (Director, EVP)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 1996-06-03 | Stock Options (right to buy) | $14.167 | A | 22500 | Acquired | 2006-06-03 | Common Stock (22500) | Direct |
| 1997-12-29 | Stock Options (right to buy) | $14.0625 | A | 37500 | Acquired | 2007-12-29 | Common Stock (37500) | Direct |
| 1999-12-15 | Stock Options (right to buy) | $26.7917 | A | 15000 | Acquired | 2006-12-15 | Common Stock (15000) | Direct |
| 1999-12-10 | Stock Options (right to buy) | $25.5833 | A | 21429 | Acquired | 2006-12-10 | Common Stock (21429) | Direct |
| 2001-08-22 | Stock Options (right to buy) | $10.56 | A | 125000 | Acquired | 2008-08-22 | Common Stock (125000) | Direct |
| 2003-08-14 | Stock Options (right to buy) | $7.74 | A | 150000 | Acquired | 2003-08-14 | Common Stock (150000) | Direct |
Footnotes
F1: Stock Options are fully vested and exercisable.
F2: Exempt stock option grant that vests over three years in equal installmentsof 33% per year beginning twelve months after date of grant (08/21/2001).
F3: Exempt stock option grant that vests over three years. First two years vesting is 33%. Third year vesting is 34%. Vesting begins twelve months after date of grant (08/14/2003).
More from MASTEC INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 22
Earnings Release
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Mar 20